Skip to NavigationSkip to content


Read the January/February 2020 edition of Pharmafocus online now!

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got done – or at least, the first step in a long process – and the UK will leave the European Union at 11pm on 31 January.

It’s a path paved with uncertainty, but it does provide clarity for business and industry which have been previously unable to plan ahead in such a divided climate.

Majority of British people worried about the fate of the NHS in post-Brexit US trade deal, survey reveals

In a newly released survey on “Over-The-Counter (OTC) and Pharma 2019”, by the business data platform Statista, 55% of people surveyed were concerned about the potential post-Brexit trade deal with the US and its impact on the NHS.

The survey assessed the responses of more than 2,000 British consumers. The NHS being part of a UK-US trade deal was first touted back in June by US Ambassador to the UK, Woody Johnson.

Damage control: How will pharma manage the health economic impacts of Brexit?

Published on 23/10/19 at 11:00am

When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the EU. With services already stretched to breaking point and key patients already unable to access the crucial medicines they need, how will the UK’s health economics be hit by an incoming Brexit?

“No deal” Brexit and life sciences: What happens?

Published on 21/10/19 at 11:51am

Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite the best efforts of UK Parliament a "no deal" exit could still present a viable threat. It's still all to play for over the next week or so in Westminster, but in the event that the Prime Minister's deal does not gain the support of Parliament or if "no deal" emerges at a later date, where does this leave the UK’s life sciences? Tim Matthews, Partner at legal firm Barlow Robbins LLP, explains.

Read the September edition of Pharmafocus online now!

The latest monthly edition of Pharmafocus, the September issue, is available to read for free online now!

With a new Prime Minister, a renewed drive to vacate the European Union by the fixed date of 31 October by any means necessary, but a distinct lack of any tangible negotiation strategy – or indeed, any evidence of negotiations at all – the UK looks to be hurtling towards a no-deal Brexit.

Top Ten most popular articles on this week

It's Friday, meaning the weekend is within reach and it's time for a rundown of the most popular articles on over the past seven days:

10. Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

Ireland will not suffer immediate medicine shortages in event of no-deal Brexit, says health authority

Though MPs are moving forward with their plan to block UK Prime Minister Boris Johnson’s supposed no-deal Brexit from the EU and the economic and medical harm that would cause, it has become known that Ireland will not succumb to the same medicine access issues that threaten too affect England.

Responding to Michael Gove, the Government’s Chancellor of the Duchy of Lancaster who has taken charge of planning for a no-deal exit, health officials said that two years of planning now mean that such an exit would not have an immediate impact on supply levels.

No-deal Brexit will "make the disintegration of the health service an ever more real prospect”, BMA warns

As the UK hurtles towards a catastrophic and autocratic exit from the European Union, the British Medical Association (BMA) has warned of the “devastating impact” a no-deal Brexit would inflict on an already underfunded NHS over the challenging winter period.

The briefing paper, titled A health service on the brink: The dangers of a 'no deal' Brexit, details the wide-ranging damage such an exit would reap during a period when demand for the health service spikes each year.

British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal

The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that the UK will be leaving on the existing deal on 31 October 2019.

Those who think there will be a further delay to Brexit make up the biggest groups in America (41%) and Britain (38%), while 43% of Europeans believe the UK will leave with a no-deal Brexit.

In contrast just 24% of Americans and 16% of Britons think that a no-deal Brexit is the most likely option on 31 October 2019.

Britain call on companies to bid for 24 hour Brexit medicines shipping service contract

The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers carrying daily shipments of medicines into the UK after the Brexit deadline on 31 October.

The Department of Health and Social Care (DHSC) said the contract would form part of the UK’s contingency plans to deal with complications associated with Britain’s departure from the EU.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches